A German medical device and services company agreed to settle charges of violating the anti-bribery, books and records, and internal accounting controls provisions of the Foreign Corrupt Practices Act.
Global medical device manufacturer Zimmer Biomet Holdings, Inc. settled criminal and civil charges brought by the DOJ and SEC after the company was found to have violated a 2012 agreement settling previous Foreign Corrupt Practices Act allegations.
The SEC charged Texas-based medical device company Orthofix International N.V. with violating the Foreign Corrupt Practices Act (FCPA) when a subsidiary paid routine bribes referred to as "chocolates" to Mexican officials in order to obtain lucrative sales contracts with government hospitals. View...
Request delivery of the Cadwalader Cabinet Newsletter.